Pandit, S.K.; Sandrini, G.; Merulla, J.; Nobili, V.; Wang, X.; Zangari, A.; Rinaldi, A.; Shinde, D.; Carbone, G.M.; Catapano, C.V.
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. Cancers 2021, 13, 6029.
https://doi.org/10.3390/cancers13236029
AMA Style
Pandit SK, Sandrini G, Merulla J, Nobili V, Wang X, Zangari A, Rinaldi A, Shinde D, Carbone GM, Catapano CV.
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. Cancers. 2021; 13(23):6029.
https://doi.org/10.3390/cancers13236029
Chicago/Turabian Style
Pandit, Shusil K., Giada Sandrini, Jessica Merulla, Valentina Nobili, Xin Wang, Alessia Zangari, Andrea Rinaldi, Dheeraj Shinde, Giuseppina M. Carbone, and Carlo V. Catapano.
2021. "Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma" Cancers 13, no. 23: 6029.
https://doi.org/10.3390/cancers13236029
APA Style
Pandit, S. K., Sandrini, G., Merulla, J., Nobili, V., Wang, X., Zangari, A., Rinaldi, A., Shinde, D., Carbone, G. M., & Catapano, C. V.
(2021). Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. Cancers, 13(23), 6029.
https://doi.org/10.3390/cancers13236029